跳转至内容
Merck
CN

U4010

Sigma-Aldrich

尿激酶 来源于人类肾脏细胞

lyophilized powder

登录查看公司和协议定价

别名:
尿纤溶酶原激活物
CAS号:
EC 号:
MDL编号:
UNSPSC代码:
12352204
eCl@ss:
32160410
NACRES:
NA.54

质量水平

形式

lyophilized powder

分子量

heavy chain 30,400 Da
light chain 2000 Da

储存温度

2-8°C

正在寻找类似产品? 访问 产品对比指南

应用

人肾细胞产生的尿激酶已被用作消化混合物的成分,用于三维纤维蛋白培养。也用于纤溶酶原激活试验。

生化/生理作用

尿激酶可促进肾肿瘤细胞的增殖。
尿激酶是一种蛋白酶,能裂解纤溶酶原形成纤溶酶。与细胞表面受体 (uPAR) 结合,在组织重塑过程中调节细胞粘附和迁移,并激活细胞内信号通路。尿激酶由三个结构域组成:与表皮生长因子同源的氨基末端结构域通过中央圈形区结构域连接到羧基端的蛋白酶结构域。

物理属性

主要活性成分是尿激酶的低分子量形式,由 2,000 道尔顿的 A 链和 30,400 道尔顿的 B 链通过巯基键连接而成。
供应的冻干粉,含有人血白蛋白、甘露醇和 NaCl。

其他说明

注:当人纤维蛋白溶酶原作为底物时,活性更高。

象形图

Health hazard

警示用语:

Danger

危险声明

预防措施声明

危险分类

Resp. Sens. 1

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

常规特殊物品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hematopoietic-to-mesenchymal transition of adipose tissue macrophages is regulated by integrin beta and fabricated fibrin matrices
Gavin KM, et al.
Adipocyte, 6(3), 234-249 (2017)
J C Kirchheimer et al.
Carcinogenesis, 9(11), 2121-2123 (1988-11-01)
Primary cultures of renal cell carcinomas and of the corresponding normal adjacent kidney tissue from 6 patients were analyzed for the effects of exogenously added urokinase-type plasminogen activator on cell proliferation as compared to the effects of tissue type plasminogen
Benjamin J Buckley et al.
International journal of molecular sciences, 22(6) (2021-04-04)
The K+-sparing diuretic amiloride shows off-target anti-cancer effects in multiple rodent models. These effects arise from the inhibition of two distinct cancer targets: the trypsin-like serine protease urokinase-type plasminogen activator (uPA), a cell-surface mediator of matrix degradation and tumor cell
Gee Young Lee et al.
ACS nano, 7(3), 2078-2089 (2013-02-14)
The tumor stroma in human cancers significantly limits the delivery of therapeutic agents into cancer cells. To develop an effective therapeutic approach overcoming the physical barrier of the stroma, we engineered urokinase plasminogen activator receptor (uPAR)-targeted magnetic iron oxide nanoparticles
Helena Enocsson et al.
Translational research : the journal of laboratory and clinical medicine, 162(5), 287-296 (2013-08-07)
Assessments of disease activity and organ damage in systemic lupus erythematosus (SLE) remain challenging because of the lack of reliable biomarkers and disease heterogeneity. Ongoing inflammation can be difficult to distinguish from permanent organ damage caused by previous flare-ups or

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门